ESMO members: The 2nd edition of the Essentials for Clinicians is available to download!
Slides from the courses on Head & Neck Cancers , Colorectal Cancer and Immuno-Oncology are open to all!
Haven't had much time lately? Here's what you may have missed in the last few weeks.
Sign-up to receive the OncologyPRO alert
every 2 weeks.
New! e-Update on Gastric Cancer Treatment Recommendations
Find all the latest ESMO Guidelines
and
discover the ESMO Guidelines Slide Sets
!
For full access to all OncologyPRO content: daily medwireNews, ESMO books, slides and webcasts... and much more.
Become an ESMO member today!
26 Jun 2019
The PD-1 antibody toripalimab given alone or alongside oxaliplatin plus capecitabine may offer a novel treatment for chemotherapy-refractory gastric...
25 Jun 2019
US researchers dispute the hypothesis that use of corticosteroids may hamper non-small-cell lung cancer response to immunotherapy
24 Jun 2019
The benefits of a novel systemic treatment for tenosynovial giant cell tumours must be weighed against its risk of hepatotoxicity
21 Jun 2019
Epacadostat plus pembrolizumab does not improve survival for patients with unresectable or metastatic melanoma over that achieved with pembrolizumab...
20 Jun 2019
Patients with advanced triple-negative breast cancer and recurrent ovarian cancer have responded to treatment with the PARP inhibitor niraparib given...
E. Efstathiou reports on study results presented on prostate cancer at ASCO 2019. She explains the benefits of adding hormonal agents early in the disease spectrum, and discusses the prospect of combinatorial strategies based on biomarkers selection.
- LBA2 / Overall survival (OS) results of ENZAMET (ANZUP 1304) trial
- Abstract 5006 / First results from TITAN trial
- Abstract 5008 / Alliance A031201: A phase III trial in mCRPC
14-15 Jun 2019, Barcelona, Spain
17-18 May 2019, Valencia, Spain
10-11 May 2019, Zurich, Switzerland
07-08 May 2019, Zurich, Switzerland
02-04 May 2019, Berlin, Germany
26-27 Apr 2019, Lugano, Switzerland
13-14 Apr 2019, Hong Kong
12-13 Apr 2019, Prague, Czech Republic
12-17 Apr 2019, Sibenik, Croatia
10-13 Apr 2019, Geneva, Switzerland
03-07 Apr 2019, Lima, Peru
24-28 Mar 2019, Berlin, Germany
22-24 Mar 2019, Sao Paulo, Brazil
14-16 Mar 2019, Barcelona, Spain
06-08 Mar 2019, Manchester, United Kingdom
